Connect with us

Stocks

Over Half of the DSE money are still trapped at floor prices

Published

on

DSE

The stock market with the unusual floor price support has regained vibrancy to generate over Tk1,000 crore in turnover daily and people on the street are talking about which stock to chase right now for astounding gains.

Everything is happening providing 52pc of scrips stuck on the price floor that came into result from the last trading session of July.

Hence, the 4 October market report by the research team of brokerage firm Royal Capital Ltd, 193 of the 369 scrips in the Dhaka Stock Exchange (DSE) were stuck at the floor price – which means there were lots of sale orders amid no buyers at the lowest allowable price.

The price floor being loved by a large number of dealers, mostly retail ones, is also frustrating significant market participants, especially institutional investors, who want the market to remain free enough to find more buyers and sellers for the sake of exchangeability and a genuine price discovery mechanism.

Blue-chip shares, that are stuck on the floor, increased the agonies of serious investors as many are unable to sell large-cap stocks such as Grameenphone (GP), Square Pharmaceuticals, BRAC Bank, Renata, Singer Bangladesh, regardless of their need for cash or will to hold onto trades.

10 of the 30 blue chip companies on the DSE are hibernating on the floor having bare trades at the price level.

BAT Bangladesh, BRAC Bank, Fortune Shoes, Grameenphone,(GP), Islami Bank, LankaBangla Finance, Renata, Robi, Singer Bangladesh and Square Pharmaceuticals were the DS30 companies stuck on the floor on Tuesday.

Like many, CFA Society Bangladesh President Shaheen Iqbal in a recent capital market hosted a show, suggests that the floor price should not be in place because it was causing the price and preventing the development of the capital market.

A stock might go down and also come back to its fair level in a free environment, he said, referring to the argument that a fall in stock prices is not the end of the world.

The floor steroid, hence, worked in helping the market recover from its 14-month low at the end of July.

DSEX, the broad-based index of the DSE surged by 9.43pc to 6,544 on Tuesday, from 5,980 on 28 July 2022.

The Bangladesh Securities and Exchange Commission (BSEC) made the price floor effective from 31 July, which is not allowing any money to trade below the then price level.

Responding to the criticisms of the stock market regulator’s repeated market disruption moves, BSEC Chairman Professor Shibli Rubayat-Ul-Islam in August said that the commission was undone because of the market structure – the dominance of retail investors who needs some protection.

Floor is so strong in the investors’ psyche in the bourses of Dhaka and Chattogram that a rumor in early September that the regulator might revoke the controversial price floor triggered a massive selloff in the stock market and the market later bounced back after the top BSEC officials’ promises that the commission was not even thinking of anything like that.

 

Share this
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Stocks

National Polymer Announce Their Dividends & Q2 Financials

Published

on

One of the Listed companies, National Polymer Limited has recommended 10.50% Cash Dividend for the year ended June 30, 2024.

It has reported Consolidated EPS of Tk 2.27 paisa, and Consolidated NAV per share of Tk 30.63 for the year ended March 31, 2024.

The Annual General Meeting (AGM) of the company will be held on December 18, through the digital platform. The record date for this has been fixed at October 22.

The Company also discloses its financial reports for the second quarter, (April – June 24).

As per the company’s consolidated life revenue account for April to June 2024, the excess of total income over total expenses, including claims (surplus), stood at Tk 1,394.24 million. This marks a significant increase from the surplus of Tk 823.68 million during the same period in 2023.

For the first half of 2024, from January to June, the company reported a surplus of Tk 2,177.57 million, compared to Tk 1,290.39 million in the corresponding period of the previous year.

Additionally, the Life Insurance Fund balance as of June 30, 2024, reached Tk 55,188.62 million, showing a net increase of Tk 5,892.25 million from Tk 49,296.37 million on June 30, 2023.

Share this
Continue Reading

Stocks

Beacon Pharma Declares Their Dividends

Published

on

One of the Listed companies, Beacon Pharmaceuticals PLC has recommended 20% Cash dividend and 10% Cash Dividend to Sponsor Shareholder and Directors for the year ended June 30, 2024.

It has reported EPS of Tk 2.26 paisa, and NAV per share of Tk. 26.37 for the year ended June 30, 2024.

The Annual General Meeting (AGM) of the company will be held on December 23, through the digital platform. The record date for this has been fixed at October 27.

Share this
Continue Reading

Stocks

BSEC Delists Three Auditors for FRC Failure

Published

on

bsec salman s alam group

The Bangladesh Securities and Exchange Commission (BSEC) has removed three audit firms from its panel for their failure to secure enlistment with the Financial Reporting Council (FRC), according to a notice issued today.

The firms—A Hoque & Company, FAMES & R, and SK Barua & Company Chartered Accountants—were delisted following the FRC’s request. In December last year, the FRC published a list of enlisted audit firms and subsequently, in February, requested the BSEC to remove any firms that were not included on that list.

BSEC regulations mandate that financial statements signed by auditors outside its approved panel will not be accepted. With the removal of these three firms, the total number of audit firms on the BSEC panel has been reduced from 48 to 45.

Sources from the FRC revealed that 15-20 audit firms failed to secure enlistment last year, and approximately 45 chartered accountants are currently under restrictions imposed by the Institute of Chartered Accountants.

Although the delisted firms can no longer audit issuer companies or listed securities, they are allowed to complete audit and assurance services that were initiated before their removal, the BSEC clarified.

Share this
Continue Reading